Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Intricon's Business Segments

Intricon's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY
Reportable Segments
-
Per the company's own filing, this quarter
Largest Segment
-
Total Revenue
$ 33
Consolidated, this quarter
Regions Reported
3
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/IIN/segments
https://api.csimarket.com/api/v1/companies/IIN/geographic
https://api.csimarket.com/api/v1/companies/IIN/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Intricon does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.

Revenue Share by Region - FY

15%largest
  • All Other Countries15.2%
  • Asia6.2%
  • Europe5.9%

Revenue by Geographic Region - FY

RegionPeriodRevenue
(Millions)
% of Total
All Other CountriesFY$ 515.2%
AsiaFY$ 26.2%
EuropeFY$ 25.9%

Revenue by Product & Service Category - FY

62%largest
  • Diabetes61.5%
  • Interventional Catheters9.9%
  • Legacy OEM8.2%
  • Medical Biotelemetry Other7.1%
  • Professional Audio Communications3.7%
  • Hearing Health Value Based ITEC3.5%
  • Hearing Health Direct to Consumer DTC Market2.1%

Revenue by Product & Service Category - FY

CategoryPeriodRevenue
(Millions)
% of Total
DiabetesFY$ 2061.5%
Interventional CathetersFY$ 39.9%
Legacy OEMFY$ 38.2%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

4 more categories available

Sign in to unlock the full Intricon dataset.

Description of Intricon

IntriCon Corporation is an international company engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company serves the body-worn device market by designing, developing, engineering, manufacturing and distributing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the emerging value hearing health market, the medical bio-telemetry market and the professional audio communication market. The Company, headquartered in Arden Hills, Minnesota, has facilities in Minnesota, California, Singapore, Indonesia, the United Kingdom and Germany, and operates through subsidiaries. The Company is a Pennsylvania corporation formed in 1930, and has gone through several transformations since its formation. The Company’s core business of body-worn devices was established in 1993 through the acquisition of Resistance Technologies Inc., now known as IntriCon, Inc. The majority of IntriCon’s current management came to the Company with the Resistance Technologies Inc. acquisition, including IntriCon’s President and CEO, who was a co-founder of Resistance Technologies Inc.
IntriCon Corporation is a company that predominantly focuses on developing and providing innovative solutions across three main markets: medical bio-telemetry, value hearing health, and professional audio communications. Their extensive expertise in core technologies aligns with the growing demand for advanced, portable devices that emphasize power efficiency and miniaturization.

Core Technologies
IntriCon has significantly invested in four critical core technologies that form the backbone of its product offerings:

1. Ultra-Low-Power (ULP) Digital Signal Processing (DSP)
2. Ultra-Low-Power (ULP) Wireless
3. Microminiaturization
4. Miniature Transducers

These technologies enable the development of highly efficient, miniature devices ideal for body-worn applications, allowing for enhanced mobility and effectiveness.

Product Line and Applications

1. Ultra-Low-Power (ULP) Digital Signal Processing (DSP)
- nanoDSP™ Technology: IntriCon provides a wide array of ULP DSP amplifiers suitable for hearing, medical, and professional audio applications. The nanoDSP technology blends ultra-miniature hardware with advanced signal processing algorithms, resulting in smaller, more effective devices.
- Reliant CLEAR™ Feedback Canceller: This product features improvements that offer stable gain and faster reaction times, enhancing acoustic performance for users.
- Audion8™ and Audion16™ Amplifiers: These new hearing aid amplifiers boast eight-channel and sixteen-channel configurations, respectively. Designed for versatility, they include multiple compression channels and a complete range of adaptive features to facilitate an improved user experience.

2. Ultra-Low-Power (ULP) Wireless
- BodyNet™ Technology: This technology encompasses various wireless systems, including nanoLink™ and PhysioLink™, which can transmit activities from the human body to caregivers or provide audio links for professional communications and surveillance.
- Applications: BodyNet applications include monitoring of vital signs (such as ECG diagnostics), diabetes management, sleep apnea research, and seamless audio streaming for hearing devices.
- PhysioLink Wireless Technology: This state-of-the-art system is nearing commercialization and leverages a proprietary4GHz digital radio protocol. It enables audio and data streaming specifically designed for both ear-worn and body-worn devices, functioning effectively over distances of up to five meters.

3. Microminiaturization
- With over 30 years of expertise in miniaturization, IntriCon specializes in creating compact medical devices and components. Their approach allows them to produce devices that are often less than one cubic inch.
- They focus on delivering very low-power solutions, identifiable by their diminished battery requirements, which further contribute to the compact dimensions of their products.

4. Miniature Transducers
- IntriCon’s advanced transducer technology includes miniature medical coils and micro coils designed for specific applications, such as pacemaker programming and interventional catheter positioning.
- Their transducer offerings are a testament to their dedication to pushing the boundaries of what’s possible in terms of both size and performance, especially in interventional care settings where precision is critical.

Conclusion
Overall, IntriCon Corporation stands at the intersection of advanced technology and healthcare solutions, channeling their expertise into developing highly innovative products that shape the future of medical bio-telemetry, hearing health, and professional audio communications. Their commitment to miniaturization, low-power technologies, and sophisticated signal processing positions them as a leader in the industry, catering to the evolving needs of healthcare professionals and consumers alike.
Get the full CSIMarket dataset: Subscribe API License